Investigational drug (as of November 2002), a dual reuptake inhibitor for both serotonin and norepinephrine, being studied as an antidepressant and for control of pain and stress urinary incontinence.
Related categories 1
Sites 3
Loading new listings for you to review...
- Duloxetine Antidepressant Action Begins in One Week Report on study findings announced in October 2002. [MedScape - Free registration required.]
- Cymbalta Manufacturer's site for this selective serotonin and norepinephrine reuptake inhibitor (SSNRI), approved in the US to treat diabetic peripheral neuropathic pain and major depression.
- MedlinePlus: Duloxetine Features information about dosage, usage, warnings, and side effects.